Audien Hearing Atom vs Resound Vivia 9 60S microRIE

The Audien Hearing Atom is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.3/5 in our lab testing. At $89, it represents one of the most affordable entry points into amplification, though its performance reflects that positioning with a rank of #52 among 65 OTC hearing aids tested. The Atom's standout strength is its excellent feedback handling, scoring a perfect 5.0/5—above the category average by 0.46 points. This means users can expect stable amplification without the whistling that can plague some budget devices. However, speech performance is more limited: speech in quiet scores a mixed 2.6/5 (0.15 points below category average), while speech in noise drops to a low 1.0/5 (0.48 points below average). A significant limitation is the complete lack of music streaming capability, scoring 0.0/5—nearly 2 points below the already-modest category average. Own-voice comfort also falls below average at 2.1/5. These results suggest the Atom is designed purely for basic amplification rather than multimedia use. The Atom may suit buyers seeking the most affordable path to mild amplification who prioritize stability over advanced features. However, several competitors in the same price range offer substantially better performance—some scoring a full point higher. Those willing to consider alternatives may find meaningfully better speech clarity and additional capabilities without significant price increases.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.